<DOC>
	<DOCNO>NCT01012388</DOCNO>
	<brief_summary>Post marketing study assess likelihood hypertropic scarring , keloid formation hyper- hypopigmentation patient Fitzpatrick Skin Types IV , V , VI receive nasolabial fold treatment Radiesse® Injectable Dermal Filler</brief_summary>
	<brief_title>Radiesse® Injectable Dermal Filler Treatment Nasolabial Folds Persons Color</brief_title>
	<detailed_description />
	<criteria>Is least 18 year age . Has Fitzpatrick Skin Type IV , V , VI . Understands accepts obligation receive procedure treatments nasolabial fold 6 month . Has history hyper hypopigmentation nasolabial fold , keloid formation , hypertrophic scarring . Has know bleed disorder receive drug therapy could increase risk bleed . Has nasolabial fold severe correct one treatment session . Has receive dermal filler injection , graft surgery either nasolabial fold . Is pregnant , lactating , use acceptable contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Moderate severe wrinkle fold nasolabial fold</keyword>
</DOC>